ChiCTR2000039243: Clinical study of RD13-01 cell Injection in the treatment of patients with recurrent or refractory T/NK line malignant hematologic tumor |
|
|
| Recruiting | 1 | 36 | | The infusion of 2.0×10^6 CART+ cell/kg ;The infusion of 5.0×10^6 CART+ cell/kg ;The infusion of 1.0×10^7 CART+ cell/kg ;The infusion of 5.0×10^6 CART+ cell/kg ;The infusion of 1.0×10^7 CART+ cell/kg ;The infusion of 3.0×10^7 CART+ cell/kg | JiangSu Province Hospital; JiangSu Province Hospital, Supported by Nanjing Bioheng Biotech Co.,Ltd | Relapsed or refractory CD7 Positive T / NK hematological malignancies | | | | |
